J. Bermejo

Comparison of Predictors and Mortality Between Bloodstream Infections Caused by ESBL-Producing Escherichia coli and ESBL-Producing Klebsiella pneumoniae

A. Oliver, R. Bonomo, Y. Carmeli, 2018, Infection Control & Hospital Epidemiology.

Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study.

A. Oliver, E. Pérez-Nadales, R. Bonomo, 2017, The Lancet. Infectious diseases.

A Multinational, Preregistered Cohort Study of β-Lactam/β-Lactamase Inhibitor Combinations for Treatment of Bloodstream Infections Due to Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae

A. Oliver, R. Bonomo, Y. Carmeli, 2016, Antimicrobial Agents and Chemotherapy.

Predictors of outcome in patients with severe sepsis or septic shock due to extended-spectrum β-lactamase-producing Enterobacteriaceae.

A. Farcomeni, A. Oliver, R. Bonomo, 2018, International journal of antimicrobial agents.

Empiric Therapy With Carbapenem-Sparing Regimens for Bloodstream Infections due to Extended-Spectrum &bgr;-Lactamase–Producing Enterobacteriaceae: Results From the INCREMENT Cohort

A. Oliver, R. Bonomo, Y. Carmeli, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Ertapenem for the treatment of bloodstream infections due to ESBL-producing Enterobacteriaceae: a multinational pre-registered cohort study.

A. Oliver, R. Bonomo, Y. Carmeli, 2016, The Journal of antimicrobial chemotherapy.

Development and validation of the INCREMENT-ESBL predictive score for mortality in patients with bloodstream infections due to extended-spectrum-&bgr;-lactamase-producing Enterobacteriaceae

A. Oliver, R. Bonomo, Y. Carmeli, 2017, The Journal of antimicrobial chemotherapy.

A Predictive Model of Mortality in Patients With Bloodstream Infections due to Carbapenemase-Producing Enterobacteriaceae.

A. Oliver, R. Bonomo, Y. Carmeli, 2016, Mayo Clinic proceedings.